Address
MPM Capital
601 Gateway Boulevard
Suite 350
South San Francisco, CA 94080
United States
Phone
Email
Website
Recent investment activity
KANDO id: 30789
Relation
Renamed to
Funding rounds
Top investment portfolio themes
nanotechnology (1)
Investment activity status
Active investor
Selected investments
Displaying 26 - 50 of 71Company | Profile | Country | Date | Funding | ||
---|---|---|---|---|---|---|
Nevro Corp | Medical device company marketing novel neuromodulation therapies for the treatment of chronic, intractable pain. | N/A | ||||
Nevro Corp | Medical device company marketing novel neuromodulation therapies for the treatment of chronic, intractable pain. | Series A | ||||
Omrix Biopharmaceuticals Inc | N/A | |||||
Orexigen Therapeutics Inc | N/A | |||||
Pacira Pharmaceuticals Inc | Acute care specialty pharmaceutical company. | N/A | ||||
Proteon Therapeutics Inc | Series B | |||||
Quantum Dot Corp | N/A | |||||
QuatRx Pharmaceuticals Co | N/A | |||||
Radius Health Inc | A biopharmaceutical company, engages in the discovery and development of therapeutics for the treatment of osteoporosis | Series B | ||||
Rhythm Pharmaceuticals Inc | Series A | |||||
Rigel Pharmaceuticals Inc | N/A | |||||
Sonic Innovations Inc | N/A | |||||
Syndax Pharmaceuticals Inc | A clinical development company focused on novel oral therapies for cancer. | N/A | ||||
Syrrx Inc | Combines high-throughput structure determination, HTS, combinatorial and medicinal chemistry together with computational methods to discover novel sma | N/A | ||||
Tercica Inc | A biopharmaceutical company developing new therapeutics for endocrine system disorders. | N/A | ||||
Theraclone Sciences Inc | Series B | |||||
Theraclone Sciences Inc | N/A | |||||
Valeritas Inc | N/A | |||||
VLST Corp | N/A | |||||
Xanodyne Pharmaceuticals Inc | Specialty pharmaceuticals for pain and women's health | Series D | ||||
Xoft Inc | Developer of electronic brachytherapy (eBx) systems for radiation oncology applications. | Series D | ||||
23andMe Inc | DNA testing and genome sequencing firm. | Series D Initial investment | ||||
Acceleron Pharma Inc | Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases. | Series F Follow-on investment | ||||
Acceleron Pharma Inc | Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases. | Series D Follow-on investment | ||||
Acceleron Pharma Inc | Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases. | Series C Initial investment |